Celegence, a Global Regulatory Affairs Services & Technology company for the Life Sciences Industry, partnered with Regulatory Affairs Professionals Society (RAPS) in July to offer a webcast “Taking Advantage of the EU MDR Delay in Uncertain Times – Optimizing Your Medical Device RA/QA Strategy”.
By replaying this webinar, you will have an opportunity to develop a comprehensive, and advanced understanding of the potential strategic solutions for EU MDR compliance, regardless of where you are in the transition process.
Additionally, you will also learn how to proactively take advantage of the extension for both MDD renewal and EU MDR implementation to effectively manage every facet of the regulatory change. This post contains the Q&A session from the webinar – giving you the answers to the most common questions that were asked about the EU MDR.
If you were not able to attend this webinar, here’s a link where you can view the on-demand version. We are here to help address any other questions that you may have related to the webinar, or questions about how you may be able to benefit from our MDR compliance services or technology, we are happy to assist. Contact us to find out how we can help you optimize your RA/QA strategy.